Alex McFarland
Alex McFarland
Contributor, The Yuan

Alex McFarland is a Brazil-based writer from the United States who writes extensively on artificial intelligence for several of the globe’s top AI platforms on topics such as the ethical implication of AI and how it can be used to improve lives. He is a regular contributor to, a top online AI-news platform in the United States, and develops content for Mind AI, ranked as 2019’s most innovative company in Korea. 

AI Continues Its Inroads Into Brazil’s Health Sector
Emerging Market
Brazil was slow off the mark to embrace the possibilities of new technologies when AI announced itself in dramatic fashion at the turn of the new century, but now, the nation is leading the race in South America. Alex McFarland looks at how Brazil got up to speed with a new game plan to address its shortcomings, and nowhere is this more evident than in healthcare.
Alex McFarland,  |  Sep 23, 2021
How AI Can Help Combat the Opioid Epidemic
The opioid epidemic has been ravaging communities throughout the US for the past few years, with very little indication of a brighter future. And as the country, and entire globe, continues to deal with the ramifications of COVID-19, there is serious concern that it will drastically worsen the opioid crisis unless the government intervene with a human-centered approach.
Alex McFarland,  |  Aug 17, 2021
Medical AI Breaks New Ground
AI is the key to solving many of the world’s greatest problems and nowhere more so than in healthcare. The medical sector witnesses almost daily breakthroughs, but to understand where it is heading requires a look at individual areas such as brain-machine interfaces, prosthetics, nanodevices, diagnosis accuracy, and DNA-based technology, among the countless tools under development.
Alex McFarland,  |  Jun 30, 2021
AI Unravels Stealthy Illness Conundrum
Alzheimer’s disease is a leading form of dementia accounting for 60 to 70 percent of the 50 million cases of dementia all around the globe. This number is expected to double every 20 years, meaning 82 million people will have it in 2030 and 152 million in 2050. While there is no known cure, AI is leading the fight against the illness.
Alex McFarland,  |  Jun 29, 2021